David Rosenthal M.D.

CellsBin is a precision medicine tech-bio company leveraging AI and nanophotonics to precisely identify and characterize rare cells with unmatched sensitivity and scalability, advancing the development and efficacy of cell-based therapies. The CellsBin™ family of products is designed to evaluate the persistence and functional efficacy of therapy cells, as well as their impact on tumor burden, through simple blood tests, eliminating the need for invasive biopsies. Our recently launched product, CB-Scout™, monitors the persistence and functional efficacy of CAR-T and CAR-NK cells at concentrations as low as 1 in 10,000,000 (one thousand times more sensitive than flow cytometry) while providing functional insights beyond the reach of molecular methods like PCR. Coming next is CB™-Insight, designed to assess cell therapy efficacy by directly measuring tumor burden in blood.

Avo is the AI platform used by healthcare enterprises to drive their most pressing initiatives by infusing trusted knowledge into clinical copilots. Avo’s platform effortlessly processes medical guidelines, payer information, and patient data in the EHR to guide more informed clinical decisions and automate end-to-end workflows across charting, documentation improvement, discharge planning, ordering, and more. By activating relevant information at the point of care, Avo transforms EHRs into intelligent systems of action, improving outcomes and saving clinicians valuable time. Visit avomd.com to learn more.

Various board memberships

High-tech, hard-tech, healthcare. Coming soon.

Fortell is designing better hearing aids for life as it’s meant to be heard. Traditional hearing aids make everything louder but they don’t do enough to help the brain separate conversation from noise in the moments that matter. Fortell changes that. Our AI-powered hearing technology doesn’t just amplify, it clarifies. Fortell uses custom AI chips to help the brain decode speech in real time, lifting voices up above the chaos so people don’t just hear, they understand. Our mission is ambitious yet deeply personal: to restore effortless connection through better hearing. Every decision we make is grounded in cutting-edge science, human-centered design, and a commitment to improving lives at scale. We are backed by Thrive Capital, Valor Equity Partners, Founders Fund, Optum Ventures, Lux Capital, Vast Ventures, Good Friends, Positive Sum, Stonecroft, and Atreides Management. Our debut product is available now at Fortell Audiology on Park Avenue and 61st Street. We move fast, build with intention, and never lose sight of the people we’re building for. We’re bringing together exceptional minds in technology, science, design, and care–and we’re just getting started. We’re hiring. Join us as we bring clarity and connection back to life.

Transcend Therapeutics, founded in 2021, is a clinical-stage, neuroscience-focused company developing rapid-acting treatments for neuropsychiatric diseases. Our mission is to develop new drugs for the millions of people for whom current psychiatric medicines have not worked. Our leadership team has made pivotal contributions to 13 FDA approvals (including recent MDD approval), $3.5B in M&A, and significant public company value creation. As a Public Benefit Corporation, we have pledged 10% of founding shares toward nonprofits focused on scientific research and access.

At Protein Evolution we’re making proteins the foundation of the next wave of scientific breakthroughs. Our journey began with Biopure™, a groundbreaking enzymatic technology that transforms plastic waste into infinitely recyclable plastic precursors — delivering both sustainability and cost-competitiveness at scale. Now, we’re opening access to the same cutting-edge tools and expertise that made Biopure™ possible—empowering companies to harness the full potential of complex chemistries and protein engineering for their own innovations.

Onda is a spirits brand for a new generation of drinkers. Onda’s first product is a line of canned tequila seltzer beverages, made with blanco tequila and real, legit juice. Onda’s beverages are 5% ABV, 100 calories, zero sugar, zero carbs and naturally gluten free. Onda’s brand is inspired by the surf style of the ‘90s. Learn more at drinkonda.com and on IG @drinkonda.

Founded in 1810, the Yale School of Medicine is a world-renowned center for biomedical research, education and advanced health care. Among its divisions are one of the nation’s oldest schools of public health and the internationally recognized Child Study Center, founded in 1911. Its Yale Cancer Center is one of 41 comprehensive cancer centers designated by the National Cancer Institute, and the school was one of the first 12 institutions to launch the Clinical and Translational Science Awards program in 2006. Its 33 academic departments include 10 in the basic sciences, 18 in clinical fields, and 5 in public health. Affiliated institutions include the 1,541-bed Yale-New Haven Hospital—flagship of the Yale New Haven Health System and one of the largest hospitals in the United States since acquisition of the Saint Raphael campus—and the Connecticut Mental Health Center, Pierce Laboratory, and VA Connecticut Healthcare System in nearby West Haven. The School of Medicine consistently ranks among the handful of leading recipients of research funding from the National Institutes of Health and other organizations supporting the biomedical sciences, and belongs to medical organizations including the Association of American Medical Colleges (AAMC) and the Association of Academic Health Centers (AAHC). The school’s unique curriculum, known as the Yale system of medical education, promotes teaching in small seminar, conference and tutorial settings, and requires student self-evaluation, independent thinking and investigation. Since 1839, Yale has required that each student complete a thesis based on original research prior to graduation. Graduates of the school have gone on to significant leadership positions in virtually every medical field, as well as many non-medical areas.

Scrub Capital is a venture capital firm powered by clinicians, operators, and digital health experts, combining deep industry knowledge with investment expertise to drive strategic health care investments. Our platform draws from our community of 650+ medical professionals who actively participate in every step of the investment process, from deal sourcing to post-investment support. Our members are not just health care professionals but founders, builders, operators, investors, and clinical leaders, uniquely positioned to reshape health tech startups through strategic investment and operational insight. This unique approach allows us to identify and nurture early-stage startups with high potential for both outsized financial returns and meaningful impact on health care’s future. Scrub Capital is actively investing. If you have promising opportunities, you can learn more and submit investment opportunities here: https://tinyurl.com/yc5ayua5 Scrub Capital is a venture capital firm that operates with the support of the broader Clinicians Who VC community- amplifying our reach and impact.

CellsBin is a precision medicine tech-bio company leveraging AI and nanophotonics to precisely identify and characterize rare cells with unmatched sensitivity and scalability, advancing the development and efficacy of cell-based therapies. The CellsBin™ family of products is designed to evaluate the persistence and functional efficacy of therapy cells, as well as their impact on tumor burden, through simple blood tests, eliminating the need for invasive biopsies. Our recently launched product, CB-Scout™, monitors the persistence and functional efficacy of CAR-T and CAR-NK cells at concentrations as low as 1 in 10,000,000 (one thousand times more sensitive than flow cytometry) while providing functional insights beyond the reach of molecular methods like PCR. Coming next is CB™-Insight, designed to assess cell therapy efficacy by directly measuring tumor burden in blood.

Avo is the AI platform used by healthcare enterprises to drive their most pressing initiatives by infusing trusted knowledge into clinical copilots. Avo’s platform effortlessly processes medical guidelines, payer information, and patient data in the EHR to guide more informed clinical decisions and automate end-to-end workflows across charting, documentation improvement, discharge planning, ordering, and more. By activating relevant information at the point of care, Avo transforms EHRs into intelligent systems of action, improving outcomes and saving clinicians valuable time. Visit avomd.com to learn more.

AlleyCorp builds and invests in transformative companies for the present and future in New York. We are humbled to partner with brilliant and determined entrepreneurs along the way. Unconstrained by industry, AlleyCorp originates the ideas, hires the early teams, funds, launches, and grows each company, and maintains an integral leadership role from beginning through exit. AlleyCorp companies have collectively raised more than $2B in venture capital and employ thousands of people in New York City and beyond. On the investment side, AlleyCorp is one of the most active early stage funds in New York. Every company we found fuels a stronger foundation for new ideas and entrepreneurs.